O'Shaughnessy Asset Management, LLC Galectin Therapeutics Inc Transaction History

O'Shaughnessy Asset Management, LLC

  • $10.8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 10, 2021
SELL
$2.59 - $4.15 $14,646 - $23,468
-5,655 Closed
0 $0
Q2 2021

Aug 09, 2021
BUY
$2.07 - $5.1 $11,705 - $28,840
5,655 New
5,655 $18,000
Q1 2021

May 14, 2021
SELL
$1.96 - $2.57 $142,129 - $186,363
-72,515 Closed
0 $0
Q4 2020

Feb 11, 2021
BUY
$2.24 - $2.87 $162,433 - $208,118
72,515 New
72,515 $162,000

Others Institutions Holding GALT

# of Institutions
93
Shares Held
9.69M
Call Options Held
1.16M
Put Options Held
1.98M
View Full List

About GALECTIN THERAPEUTICS INC

GALT Quotes by TradingView
  • Ticker GALT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,426,000
  • Market Cap $73.7M
  • Description
  • Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial f...
More about GALT
Track This Portfolio

Track O'Shaughnessy Asset Management, LLC Portfolio

Follow O'Shaughnessy Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email